Abstracts: Canadian Liver Meeting 2027

Important Dates

Abstract Submission Deadline: Wednesday, January 13, 2027

Notification Date: Early-March 2027

Conference / Abstract Themes

Submission Topics:

Autoimmune Liver Disease – Biomedical, Translational & Basic Science
Autoimmune Liver Disease - Clinical Science, Epidemiology & Public Health
ALD – Biomedical, Translational & Basic Science
ALD - Clinical Science, Epidemiology & Public Health
MASLD/MASH – Biomedical, Translational & Basic Science
MASLD/MASH - Clinical Science, Epidemiology & Public Health
Other liver disease - Biomedical, Translational & Basic Science
Other liver disease - Clinical Science, Epidemiology & Public Health
Viral Hepatitis - Biomedical, Translational & Basic Science
Viral Hepatitis - Clinical Science, Epidemiology & Public Health

Please note that the Abstract Review Committee reserves the right to re-categorize any abstract as deemed appropriate.

Process

Abstracts will undergo a peer-review process. The Abstract Review Committee will assess each abstract based on its adherence to format, scientific merit, and alignment with the overall conference themes. Authors of abstracts selected for presentation will be contacted via email by Early-March 2027 and invited to present either a poster or oral presentation at the meeting.

All selected abstracts will be made available to the Conference participants in electronic format, on the conference website.

Additionally, abstracts that are confirmed for presentation will be published in the Canadian Liver Journal.

Abstract Format

Title:

Background:

Purpose:

Method:

Result(s):

Conclusion(s):

Mitigation of Bias

Presentations must present a balanced view of the available therapeutic options. Brand names of pharmaceuticals and trade names of medical devices should not be used in the title or body of the abstract. Use of generic names will contribute to impartiality.
The Abstract Review Committee reserves the right to change the abstract if they feel that the use of a trade name may be mistaken for commercial propaganda and may replace proprietary names with generic names. In addition, logos or images of products that include a trade name or representing a commercial interest will be removed prior to presentation and publication.

Disclosure of Conflicts of Interest

The presenting authors of abstracts selected for oral presentation will be required to complete and submit a Disclosure of Conflicts of Interest form after they are invited to present. Disclosures are due on or before the RSVP deadline.

Abstract Form Submission

Please use the official online abstract submission form only.

Abstracts must be submitted electronically using the official online submission form.
Abstracts must identify the presenting author along with email address and phone number.
Please use standard abbreviations. Place special or unusual abbreviations in parenthesis after the full word when it appears for the first time.
Errors, misspellings, and incorrect abbreviations will not be corrected.
Minimize the use of charts as this detail is not used to evaluate the merit of your abstract.
Abstracts must not exceed 3000 characters (excluding the abstract heading).
An individual may submit more than one abstract. One official online submission is required for each abstract.
There is no fee to submit abstract(s).
Edits to submitted abstracts may be made up to the submission deadline. Instructions for making edits can be found on the online abstract submission form.
All submitters must identify whether their abstract has been previously submitted and/or published, but encore abstracts will be considered for presentation.

Abstract Submission Terms and Conditions

Originality of Content
Submitted abstracts must contain original data that have not been previously published or accepted for publication in a print or online journal. Abstracts should present new data, trial protocol information, analyses, or information that has not previously been presented at a major obesity or liver-related congress. Authors are responsible for ensuring that the submitted abstract does not replicate the wording of any previously published abstract.
Scientific Nomenclature
Abstracts must not contain brand or trade names. References to agents, compounds, or molecules must follow accepted scientific standards for publication.
Ethics and Regulatory Compliance
All research described in the abstract must have received any required approvals and comply with applicable local regulations, ethical standards, and animal experimentation requirements, where applicable.
Disclosure of Conflicts of Interest and Funding
The submitting author is responsible for disclosing all relevant conflicts of interest and funding sources on behalf of all authors during the abstract submission process.
Publication of Accepted Abstracts
Accepted abstracts will be published in a digital supplement of the Canadian Liver Journal and made available on the CLM Conference Website at CLM Conference Website.
Presentation Requirement
If an abstract is accepted as an oral presentation or poster, at least one author must present the work at the conference. Presenting authors must maintain a valid conference registration. Abstracts for which the presenting author is not registered by end of March, may be removed from the conference program and abstract publication.
Recording and Educational Use
If selected for oral presentation, the presenting author, on behalf of all authors, may be required to sign an agreement granting CLM the right to record the presentation, including audio and presentation slides, and to use such recordings for educational purposes, with or without a fee.
Compliance with Submission Guidelines
All submissions must adhere to the Abstract Submission Guidelines. Failure to comply with the guidelines may result in rejection of the abstract.
Acceptance of Terms
Submission of an abstract constitutes acknowledgement and acceptance of these Terms and Conditions by the submitting author on behalf of all co-authors.

Canadian Liver Meeting Young Investigator

Qualifying first authors of abstracts submitted to the Canadian Liver Meeting may apply for a Young Investigator Award. Grant application is completed by ticking a box within the abstract submission system. Awards are given to presenters of oral or poster presentations that are to be presented at the Canadian Liver Meeting 2027.

I. Purpose

The Young Investigator Awards recognize outstanding young investigators’ research accomplishments and looks to promote their travel to attend the Canadian Liver Meeting to present their research. 

II. Award

For those attending onsite, the award consists of:

one complimentary conference registration,
two nights’ accommodation at the conference hotel, and
reimbursement of travel expenses (economy flight, train ticket or mileage) up to CAD 800.

Reimbursement will be made after the meeting by bank transfer. 

III. Eligibility 

Candidates must have submitted an abstract as a first author that has been accepted for oral or poster presentation at the CLM 2027.

Candidates must be a CASL member. CASL membership is complimentary for trainees/students. Further information can be found here. 

Candidates must be a medical, nursing, nursing practitioner or graduate student, resident or fellow (clinical or post-doc researcher). 

IV. Application Process

Award application will be based on merit & criteria. Please make sure you meet the requirements. 

V. Selection Process

Abstracts will be revised and scored by the Canadian Liver Meeting Scientific Review Committee. Award applicants will be notified of their abstract submission and award application in March 2027.

Presentation at the Meeting

A number of abstracts will be selected for oral presentation; indicate on the submission form whether you are interested in being considered for an oral presentation.
If an abstract is accepted for oral presentation, the presenter(s) agree(s) to register for the conference and pay the appropriate conference registration fee. Presenters will receive a notification regarding their abstract prior to the Early Bird registration deadline in order to benefit from the reduced rate.
The Conference will not cover expenses of those presenting posters, or giving an oral presentation based on an abstract submission. Abstract submitters who may be eligible to receive such funding will be contacted separately regarding these opportunities.
Further details regarding presentation formatting will be sent to accepted abstract presenters at a later date.

Copyright Permission

By submitting abstracts to the conference, submitters authorize, upon acceptance, the permission to reproduce their abstract in the conference proceedings to be published in the Canadian Liver Journal and on the conference website.

Abstract Submission Guidelines

ABSTRACT SUBMISSION FOR CLM IS OPEN!